X4 Pharmaceuticals (XFOR) Net Equity Issued and Repurchased (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Net Equity Issued and Repurchased of $146.0 million for Q4 2025, up 68.05% on a QoQ basis from $86.9 million in Q3 2025.
X4 Pharmaceuticals (XFOR) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $146.0 million for Q4 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $146.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $232.9 million (up 353.32% YoY) and the FY2025 annual result came in at $238.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $146.0 million for Q4 2025 at X4 Pharmaceuticals, up from $86.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $146.0 million in Q4 2025 and bottomed at $2000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | 146.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146.04 Mn |
| Dec 31, 2025 | 146.04 Mn |
| Sep 30, 2025 | 86.91 Mn |
| Sep 30, 2025 | 86.91 Mn |
| Dec 31, 2023 | 51.38 Mn |
| Dec 31, 2023 | 51.38 Mn |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2017 | 5.00 Mn |
| Sep 30, 2017 | 5.00 Mn |
| Jun 30, 2017 | 253,000.00 |
| Jun 30, 2017 | 253,000.00 |